X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3030) 3030
Newsletter (54) 54
Newspaper Article (17) 17
Magazine Article (16) 16
Book Chapter (12) 12
Dissertation (5) 5
Streaming Video (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bosentan (2616) 2616
humans (1632) 1632
male (1144) 1144
pulmonary hypertension (897) 897
female (863) 863
hypertension, pulmonary - drug therapy (791) 791
endothelin (757) 757
animals (710) 710
endothelin receptor antagonists (692) 692
cardiac & cardiovascular systems (645) 645
middle aged (611) 611
pulmonary arterial hypertension (550) 550
adult (543) 543
therapy (542) 542
pharmacology & pharmacy (504) 504
sildenafil (503) 503
treatment outcome (476) 476
sulfonamides - pharmacology (475) 475
antihypertensive agents - therapeutic use (468) 468
hypertension (467) 467
respiratory system (464) 464
rats (463) 463
sulfonamides - therapeutic use (459) 459
survival (454) 454
hypertension, pulmonary - physiopathology (433) 433
double-blind (367) 367
arterial-hypertension (327) 327
aged (324) 324
medicine, general & internal (273) 273
hypertension, pulmonary - etiology (263) 263
bosentan therapy (261) 261
drug therapy (243) 243
research (231) 231
endothelin-1 (230) 230
hypertension, pulmonary - diagnosis (226) 226
prostacyclin (223) 223
expression (219) 219
care and treatment (217) 217
epoprostenol (215) 215
endothelin receptor antagonist (212) 212
pulmonary arterial-hypertension (212) 212
hemodynamics (210) 210
inhaled iloprost (207) 207
disease (199) 199
sulfonamides - administration & dosage (198) 198
antihypertensive agents - pharmacology (197) 197
scleroderma (196) 196
antihypertensive agents - administration & dosage (194) 194
diagnosis (191) 191
drug therapy, combination (183) 183
time factors (181) 181
abridged index medicus (177) 177
prognosis (177) 177
systemic sclerosis (174) 174
sildenafil citrate (172) 172
rats, sprague-dawley (170) 170
rheumatology (169) 169
vasodilator agents - therapeutic use (165) 165
blood pressure - drug effects (164) 164
dose-response relationship, drug (164) 164
nitric-oxide (163) 163
ambrisentan (162) 162
adolescent (161) 161
endothelin-receptor antagonist (161) 161
peripheral vascular disease (160) 160
receptor antagonist bosentan (160) 160
analysis (157) 157
retrospective studies (154) 154
mortality (153) 153
rats, wistar (145) 145
familial primary pulmonary hypertension (144) 144
iloprost (143) 143
surgery (143) 143
hemodynamics - drug effects (142) 142
follow-up studies (140) 140
medicine & public health (140) 140
treprostinil (139) 139
hypertension, pulmonary - mortality (138) 138
combination therapy (136) 136
risk factors (136) 136
cells (134) 134
hypertension, pulmonary - therapy (133) 133
health aspects (131) 131
antihypertensive agents - adverse effects (130) 130
administration, oral (129) 129
child (129) 129
congenital heart disease (125) 125
efficacy (125) 125
children (124) 124
prospective studies (124) 124
continuous intravenous epoprostenol (123) 123
receptor antagonist (123) 123
young adult (123) 123
pulmonary arteries (121) 121
medicine, research & experimental (120) 120
scleroderma, systemic - complications (120) 120
disease models, animal (118) 118
pharmacokinetics (118) 118
systemic-sclerosis (118) 118
endothelin-1 - metabolism (117) 117
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2912) 2912
French (69) 69
German (60) 60
Spanish (56) 56
Russian (38) 38
Japanese (30) 30
Turkish (15) 15
Portuguese (14) 14
Chinese (12) 12
Polish (7) 7
Korean (6) 6
Italian (5) 5
Czech (4) 4
Slovak (2) 2
Slovenian (2) 2
Hebrew (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The European respiratory journal, ISSN 0903-1936, 03/2007, Volume 29, Issue 3, pp. 469 - 475
Journal Article
Chest, ISSN 0012-3692, 2014, Volume 146, Issue 3, pp. 686 - 708
BACKGROUND Health-related quality of life (HRQoL) is severely impaired in pulmonary arterial hypertension (PAH). We aimed to assess the effect of PAH-specific... 
Pulmonary/Respiratory | INHALED ILOPROST | SILDENAFIL | EPOPROSTENOL | RESPIRATORY SYSTEM | PROSTACYCLIN ANALOG | EISENMENGER-SYNDROME | DOUBLE-BLIND | ORAL TREPROSTINIL | BOSENTAN THERAPY | PATIENT-REPORTED OUTCOMES | 1ST-LINE BOSENTAN | CRITICAL CARE MEDICINE
Journal Article
Biotechnology progress, ISSN 1520-6033, 2018, Volume 35, Issue 2, pp. e2748 - n/a
Journal Article
Journal Article
Journal Article
Medicine (Baltimore), ISSN 0025-7974, 03/2018, Volume 97, Issue 10, p. e0075
Background:Oral bosentan has been widely applied in pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD). A systemic review and... 
congenital heart disease | exercise capacity | hemodynamic parameters | bosentan | pulmonary arterial hypertension | ADULT PATIENTS | MULTICENTER | EFFICACY | SAFETY | EISENMENGER-SYNDROME | ORAL BOSENTAN | EXERCISE | MEDICINE, GENERAL & INTERNAL | THERAPY | TOLERABILITY | PAH
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 4, pp. 319 - 329
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 9, pp. 809 - 818
Journal Article